As of 2024-12-14, the Relative Valuation of Abivax SA (ABVX.PA) is (29.55) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 7.14 EUR, the upside of Abivax SA based on Relative Valuation is -513.9%.
The range of the Relative Valuation is (31.04) - (27.85) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.1x - 16.5x | 16.0x |
| Forward P/E multiples | 4.5x - 9.9x | 5.1x |
| Fair Price | (31.04) - (27.85) | (29.55) |
| Upside | -534.7% - -490.0% | -513.9% |
| Date | P/E |
| 2024-12-13 | -2.55 |
| 2024-12-12 | -2.66 |
| 2024-12-11 | -2.77 |
| 2024-12-10 | -2.87 |
| 2024-12-09 | -2.85 |
| 2024-12-06 | -2.85 |
| 2024-12-05 | -2.82 |
| 2024-12-04 | -2.88 |
| 2024-12-03 | -2.73 |
| 2024-12-02 | -2.80 |
| 2024-11-29 | -2.84 |
| 2024-11-28 | -2.75 |
| 2024-11-27 | -2.87 |
| 2024-11-26 | -2.80 |
| 2024-11-25 | -2.91 |
| 2024-11-22 | -3.01 |
| 2024-11-21 | -2.93 |
| 2024-11-20 | -2.94 |
| 2024-11-19 | -3.03 |
| 2024-11-18 | -3.12 |
| 2024-11-15 | -3.11 |
| 2024-11-14 | -3.35 |
| 2024-11-13 | -3.41 |
| 2024-11-12 | -3.37 |
| 2024-11-11 | -3.45 |
| 2024-11-08 | -3.43 |
| 2024-11-07 | -3.36 |
| 2024-11-06 | -3.42 |
| 2024-11-05 | -3.39 |
| 2024-11-04 | -3.44 |
| 2024-11-01 | -3.39 |
| 2024-10-31 | -3.44 |
| 2024-10-30 | -3.48 |
| 2024-10-29 | -3.53 |
| 2024-10-28 | -3.43 |
| 2024-10-25 | -3.33 |
| 2024-10-24 | -3.36 |
| 2024-10-23 | -3.41 |
| 2024-10-22 | -3.46 |
| 2024-10-21 | -3.40 |
| 2024-10-18 | -3.44 |
| 2024-10-17 | -3.29 |
| 2024-10-16 | -3.06 |
| 2024-10-15 | -3.06 |
| 2024-10-14 | -3.05 |
| 2024-10-11 | -2.96 |
| 2024-10-10 | -2.92 |
| 2024-10-09 | -2.93 |
| 2024-10-08 | -3.03 |
| 2024-10-07 | -3.10 |